Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: E.R. Squibb & Sons Limited, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH
Capoten 25 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, slightly mottled, square, biconvex tablet, with “25” embossed on one side and cross scored on the other side. The score line is to facilitate breaking for ease of swallowing and to divide into equal doses of 12.5mg (half tablet) or 6.25mg (quarter tablet). |
Each tablet contains 25 mg captopril.
Excipient(s) with known effect: Lactose monohydrate
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Captopril |
Captopril is a highly specific, competitive inhibitor of angiotensin-I converting enzyme (ACE inhibitors). Inhibition of ACE results in decreased plasma angiotensin-II, which leads to decreased vasopressor activity and to reduced aldosterone secretion. In patients with hypertension, captopril causes a reduction in supine and erect blood pressure, without inducing any compensatory increase in heart rate, nor water and sodium retention. |
| List of Excipients |
|---|
|
Lactose monohydrate |
The tablets are packaged in PVC/aluminium blisters or PVC/PVdC/aluminium blisters in packs of 28 or 84 tablets.
Not all pack sizes may be marketed.
E.R. Squibb & Sons Limited, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH
PL 00034/0193
Date of first authorisation: 27th March 1981
Date of latest renewal: 26th November 1996
| Drug | Countries | |
|---|---|---|
| CAPOTEN | Australia, New Zealand |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
